You are here

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Banner Alzheimer's Institute
Phoenix, Arizona, 85006 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Alzheimer's Disease
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
50-80 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Concern about a change in cognition expressed by the subject or by an informant that
knows the subject well

- Mini-Mental State Examination (MMSE) score ≥ 25

- Global Clinical Dementia Rating = 0.5.

- General cognition and functional performance sufficiently preserved such that a
diagnosis of Alzheimer's dementia cannot not be made by the site physician at the time
of screening.

- Amyloid burden detected on screening brain PET scan.

- Other inclusion criteria apply.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Significant neurological disease other than early Alzheimer's disease

- Major psychiatric disorder or symptom

- Contraindication to undergo brain MRI

- Unstable medical conditions

- Other exclusion criteria apply

NCT01227564
Pfizer
Completed
Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now